BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Alive Maryland - ECPv6.2.9//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://alivemaryland.org
X-WR-CALDESC:Events for Alive Maryland
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20230525T120000
DTEND;TZID=America/New_York:20230525T130000
DTSTAMP:20260421T184611
CREATED:20230515T143941Z
LAST-MODIFIED:20230515T143941Z
UID:2597-1685016000-1685019600@alivemaryland.org
SUMMARY:Prevention and Treatment of HIV and Hepatitis C in People with Opioid Use Disorder
DESCRIPTION:Among persons living with HIV in the United States\, an estimated 15 to 30% have HCV coinfection. For persons living with HIV who have HCV coinfection\, liver-related morbidity and mortality is a prominent non-AIDS-related complication—up to 80 to 90% of liver-related deaths in persons living with HIV are attributable to HCV infection-and proper treatment remains a priority. This webinar will discuss HIV/HCV co-infection\, particularly among people who inject drugs\, and evidence-based prevention and treatment strategies. \nCEU Available \nLearning Objectives: \n\nDiscuss the epidemiology of HIV and HCV infections in populations of people who use drugs\, particularly those who inject drugs.\nOutline established and emerging strategies to prevent infection in these individuals.\nEvaluate the approach to treatment of HIV and HCV in these individuals.\n\nFaculty:\nMark Sulkowski\, MD\, is a Professor of Medicine at the Johns Hopkins University School of Medicine and the Director of the Division of Infectious Diseases at Johns Hopkins Bayview Medical Center. He is founding Director of the Johns Hopkins Office of Clinical Trials and Senior Associate Dean for Clinical Trials and Research in the Capital Region (CAPRES). He also serves as the Medical Director of the Viral Hepatitis Center in the Divisions of Infectious Diseases and Gastroenterology/Hepatology in the Department of Medicine. Dr. Sulkowski has been the principal investigator for more than 120 clinical trials related to the management of viral hepatitis B and C in persons with and without HIV co-infection. \nRegister now at https://us06web.zoom.us/webinar/register/WN_g1HHR6VaQjGm8K9s1X6LLg
URL:https://alivemaryland.org/event/prevention-and-treatment-of-hiv-and-hepatitis-c-in-people-with-opioid-use-disorder/
LOCATION:Online Event
CATEGORIES:Webinar
END:VEVENT
END:VCALENDAR